Dormant tumor-suppressor pathways in tumors

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 4, 1999, Pages 541-542

  Weintraub, Steven Jay ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR;

CELL DIVISION; GENETICS; HUMAN; LUNG TUMOR; MUTATION; NEOPLASM; NOTE; ONCOGENE RAS; PATHOLOGY; SMALL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SMALL CELL; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; GENES, P53; GENES, RAS; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MUTATION; NEOPLASMS;

EID: 0033113183     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.4.f147     Document Type: Article

References (13)

1. Shih, C. B., Z. Shilo, M. P. Goldfarb, A. Dannenberg, and R. A. Weinberg. 1979. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl. Acad. Sci. USA 76:5714-5718.
2. Newbold, R. E., and R. W. Overell. 1983. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 304:648-651.
3. Land, H., L. F. Parade, and R. A. Weinberg. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222:771-778.
4. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
5. Ruley, H.E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602-606.
6. Adams, P. D., and W. G. Kaelin, Jr. 1998. Negative control elements of the cell cycle in human tumors. Curr. Opin. Cell. Biol. 10:792-797.
7. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1998. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
8. Franza, B. R., Jr., K. Maruyama, J. I. Garrels, and H. E. Ruley. 1986. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 44:409-418.
9. Lloyd, A. C. 1998. Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev. 8:43-48.
10. Weinberg, R. A. 1997. The cat and mouse games that genes, viruses, and cells play. Cell 88:573-575.
11. Ravi, R. K., A. Thiagalingam, E. Weber, M. McMahon, B. D. Nelkin, and M. Mabry. 1999. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am. J. Respir. Cell Mol. Biol 20:543-549.
12. Ravi, R. K., E. Weber, M. McMahon, J. R. Williams, S. Baylin, A. Mal, M. L. Harter, L. E. Dillehay, P. P. Claudio, A. Giordano, B. D. Nelkin, and M. Mabry. 1998. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J. Clin. Invest. 101:153-159.
13. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.